Fig 1.
Baseline hazard and survival functions for surrogate endpoint and true endpoint truncated at 8 months using the advanced ovarian cancer meta-analysis dataset.
Fig 2.
Baseline hazard and survival functions for surrogate endpoint and true endpoint, using simulated meta-analysis of 600 subjects and 30 trials.